Download presentation
Presentation is loading. Please wait.
Published byJuniper Tyler Modified over 5 years ago
1
Impact of Preoperative Angiotensin-Converting Enzyme Inhibitor Use on Clinical Outcomes After Cardiac Surgery Maral Ouzounian, MD, Karen J. Buth, MS, Liliya Valeeva, MD, Craig C. Morton, MS, Ansar Hassan, MD, PhD, Imtiaz S. Ali, MD The Annals of Thoracic Surgery Volume 93, Issue 2, Pages (February 2012) DOI: /j.athoracsur Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions
2
Fig 1 Risk-adjusted effect of preoperative angiotensin-converting enzyme inhibitor (ACEi) use on in-hospital and long-term outcomes after coronary artery bypass grafting. (ACS = acute coronary syndrome; CI = confidence interval; HF = heart failure; ICU = intensive care unit.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions
3
Fig 2 Risk adjusted freedom from mortality with and without preoperative angiotensin-converting enzyme inhibitor (ACEi) therapy. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.